首页> 外文期刊>中国癌症研究(英文版) >EFFECT OF ARSENIC TRIOXIDE OR ATRA ON PRIMARY APL CELL OR HL-60 CELLS AND THEIR VALUE ANALYSIS IN HYPERLEUKOCYTOSIS
【24h】

EFFECT OF ARSENIC TRIOXIDE OR ATRA ON PRIMARY APL CELL OR HL-60 CELLS AND THEIR VALUE ANALYSIS IN HYPERLEUKOCYTOSIS

机译:三氧化二砷或阿特拉对原发性APL细胞或HL-60细胞的影响及其在高白细胞生成中的价值分析

获取原文
获取原文并翻译 | 示例
       

摘要

Objective: To detect the effect of arsenic trioxide or ATRA on APL cells or HL-60 cells and to investigate the mechanism of the hyperleukocytosis and detect the cross resistance between ATRA and arsenic trioxide. Methods: The number of promyelocytes or more matured granulocytes were counted by regular method, MTT test was used to measure the proliferation of HL-60 cells or APL cells, flow cytometry analysis to measure the apoptosis, NBT method to detect the differentiation of HL-60 cells or APL cells. Results: The proliferation of primary APL cells or HL-60 cells could be inhibited in vitro by either arsenic trioxide or ATRA, which could induce obvious apoptosis or obvious differentiation of primary APL cells or HL-60 cells. Inhibition of proliferation or apoptosis of ATRA resistant HL-60 cells were achieved by exposure toarsenic trioxide in vitro. On the other hand, the results of in vivo treatment showed that arsenic trioxide also induce of hyperleukocytosis. Conclusion: The results indicated that the hyperleukocytosis induced by ATRA is not contributed to the mechanism of more differentiation than apoptosis, there was not cross resistance between ATRA and arsenic trioxide.
机译:目的:检测三氧化二砷或ATRA对APL细胞或HL-60细胞的作用,探讨白细胞增多的机制,并检测ATRA与三氧化二砷的交叉耐药性。方法:采用常规方法计数早幼粒细胞或成熟粒细胞的数量,MTT法检测HL-60或APL细胞的增殖,流式细胞仪检测细胞凋亡,NBT法检测HL-分化。 60格或APL格。结果:三氧化二砷或ATRA均可抑制原代APL细胞或HL-60细胞的增殖,从而诱导原代APL细胞或HL-60细胞明显凋亡或分化。体外暴露于三氧化二砷可抑制ATRA耐药HL-60细胞的增殖或凋亡。另一方面,体内治疗的结果表明三氧化二砷也诱导白细胞增多。结论:结果表明,ATRA引起的高白细胞增多与细胞凋亡没有更多的分化机制,ATRA与三氧化二砷之间没有交叉耐药性。

著录项

  • 来源
    《中国癌症研究(英文版)》 |2001年第2期|119-123|共5页
  • 作者

  • 作者单位

    Rui-Jin Hospital, Shanghai Institute of Hematology,;

    Rui-Jin Hospital, Shanghai Institute of Hematology,;

    Rui-Jin Hospital, Shanghai Institute of Hematology,;

    Department of Hematology/Oncology, Institute of Basic medicine, Shandong Academy of Medical Sciences,;

    Department of Hematology/Oncology, Institute of Basic medicine, Shandong Academy of Medical Sciences,;

    Department of Hematology/Oncology, Institute of Basic medicine, Shandong Academy of Medical Sciences,;

    Department of Hematology/Oncology, Institute of Basic medicine, Shandong Academy of Medical Sciences,;

    Department of Hematology/Oncology, Institute of Basic medicine, Shandong Academy of Medical Sciences,;

    Department of Hematology/Oncology, Institute of Basic medicine, Shandong Academy of Medical Sciences,;

    Department of Hematology/Oncology, Institute of Basic medicine, Shandong Academy of Medical Sciences,;

  • 收录信息 中国科学引文数据库(CSCD);
  • 原文格式 PDF
  • 正文语种 chi
  • 中图分类 急性白血病;
  • 关键词

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号